CANCER drug treatments are under scrutiny as a cause of soaring healthcare and claims costs. Current cancer patients will have to brace for changes.
Home Investments Fine-tuning MediShield Life: From 2022, cancer drug treatments must be in “positive...
- Advertisement -
Most Popular
Iran war unlikely to have prolonged impact on stock markets, analysts say
Staying invested in the stock market is likely the best strategy for investors amid volatility from the war in the Middle East, analysts said....
